Andrew Zannettino

Professor

  • 11097 Citations
  • 57 h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Letter
2017

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Lee, O. L., Horvath, N., Lee, C., Joshua, D., Ho, J., Szer, J., Quach, H., Spencer, A., Harrison, S., Mollee, P., Roberts, A. W., Talaulikar, D., Brown, R., Augustson, B., Ling, S., Jaksic, W., Gibson, J., Kalff, A., Johnston, A., Kalro, A. & 3 others, Ward, C., Prince, H. M. & Zannettino, A., 1 Aug 2017, In : Internal Medicine Journal. 47, 8, p. 938-951 14 p.

Research output: Contribution to journalLetter

9 Citations (Scopus)
2011
15 Citations (Scopus)
2010

Circulating levels of TWEAK correlate with bone erosion in multiple myeloma patients

Williams, S. A., Martin, S. K., Vincent, C., Gronthos, S., Zheng, T., Atkins, G. J. & Zannettino, A. C. W., 1 Aug 2010, In : British Journal of Haematology. 150, 3, p. 373-376 4 p.

Research output: Contribution to journalLetter

5 Citations (Scopus)
2008

Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?

Labrinidis, A., Liapis, V., Thai, L. M., Atkins, G. J., Vincent, C., Hay, S., Sims, N. A., Zannettino, A. C. W., Findlay, D. M. & Evdokiou, A., 1 Jun 2008, In : Blood. 111, 11, p. 5411-5412 2 p.

Research output: Contribution to journalLetter

16 Citations (Scopus)
2004

Identification and Clinical Relevance of Receptor Activator of Nuclear Factor κB Ligand Expression of Myeloma Cells [2] (multiple letters)

Heider, U., Zavrski, I., Jakob, C., Fleissner, C., Sezer, O., Zannettino, A. C. W., Pan, B., Farrugia, A. N., Atkins, G. J. & Bik To, L., 15 Jan 2004, In : Cancer Research. 64, 2, p. 773-775 3 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)